Revolution Medicines, Inc. ($RVMD)
Filing Information
| Accession Number | 0001610717-26-000230 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 17, 2026 |
| Document | View SEC Filing |
Transactions
13
Total Shares
273,575
Total Value
$17,745,559.38
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jun 15, 2026 | Exercise/Conversion | 15,546 | $40.74 | $633,344.04 | 173,768 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 15, 2026 | Exercise/Conversion | 44,854 | $29.80 | $1,336,649.20 | 218,622 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 15, 2026 | Sale | 60,400 | $160.17 | $9,674,304.24 | 158,222 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 16, 2025 | Sale | 3,575 | $156.12 | $558,126.50 | 154,647 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 17, 2026 | Exercise/Conversion | 573 | $40.74 | $23,344.02 | 155,220 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 17, 2026 | Exercise/Conversion | 3,302 | $29.80 | $98,399.60 | 158,522 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 17, 2026 | Exercise/Conversion | 25,725 | $26.50 | $681,712.50 | 184,247 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 17, 2026 | Sale | 29,600 | $160.12 | $4,739,679.28 | 154,647 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jun 15, 2026 | Exercise/Conversion | 15,546 | $0.00 | $0.00 | 75,648 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jun 15, 2026 | Exercise/Conversion | 44,854 | $0.00 | $0.00 | 75,052 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jun 17, 2026 | Exercise/Conversion | 573 | $0.00 | $0.00 | 75,075 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jun 17, 2026 | Exercise/Conversion | 3,302 | $0.00 | $0.00 | 71,750 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jun 17, 2026 | Exercise/Conversion | 25,725 | $0.00 | $0.00 | 114,275 | Direct | โ | View Details |